Advanced Biomed Inc Basic Shares Outstanding (Weighted Average)
Advanced Biomed Inc (ADVB) reported Basic Shares Outstanding (Weighted Average) of 1.28 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-05-15
- Advanced Biomed Inc weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 1.28M shares, a 25.49% increase year-over-year.
- Advanced Biomed Inc weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 21.64M shares, a 8.20% increase year-over-year.
- Advanced Biomed Inc weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 21.64M shares, a 8.20% increase year-over-year.
- Advanced Biomed Inc weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 79.08M shares, a 295.40% increase year-over-year.
- Advanced Biomed Inc weighted average number of shares outstanding, basic for fiscal 2025 was 20.53M shares, a 2.63% increase from fiscal 2024.
- Advanced Biomed Inc weighted average number of shares outstanding, basic for fiscal 2024 was 20.00M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-03-31 | 1.28M shares 10-Q · filed 2026-05-15 | 11.46M shares derived: average of 2 quarters · filed 2026-05-15 | 1.15M shares 10-Q · filed 2026-05-15 | 30.91M shares derived: average of 4 quarters · filed 2026-05-15 | ||
| 2025-12-31 | 21.64M shares 10-Q · filed 2026-02-13 | 21.64M shares 10-Q · filed 2026-02-13 | 40.79M shares derived: average of 3 quarters · filed 2026-02-13 | 30.85M shares derived: average of 4 quarters · filed 2026-05-15 | ||
| 2025-09-30 | 21.64M shares 10-Q · filed 2025-11-19 | 50.36M shares derived: average of 2 quarters · filed 2025-11-19 | 33.91M shares derived: average of 3 quarters · filed 2026-05-15 | 30.44M shares derived: average of 4 quarters · filed 2026-05-15 | ||
| 2025-06-30 | 79.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | 40.05M shares derived: average of 2 quarters · filed 2026-05-15 | 33.37M shares derived: average of 3 quarters · filed 2026-05-15 | 20.53M shares 10-K · filed 2025-10-08 | ||
| 2025-03-31 | 1.02M shares 10-Q · filed 2026-05-15 | 20.48M shares 10-Q · filed 2025-05-15 | 10.51M shares derived: average of 2 quarters · filed 2026-05-15 | 1.01M shares 10-Q · filed 2026-05-15 | 20.16M shares 10-Q · filed 2025-05-15 | 15.26M shares derived: average of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | 20.00M shares 10-Q · filed 2026-02-13 | 20.00M shares 10-Q · filed 2026-02-13 | 20.00M shares derived: average of 3 quarters · filed 2026-02-13 | 20.00M shares derived: average of 4 quarters · filed 2026-02-13 | ||
| 2024-09-30 | 20.00M shares 10-Q · filed 2025-11-19 | 20.00M shares derived: average of 2 quarters · filed 2025-11-19 | 20.00M shares derived: average of 3 quarters · filed 2025-11-19 | 20.00M shares derived: average of 4 quarters · filed 2025-11-19 | ||
| 2024-06-30 | 20.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | 20.00M shares derived: average of 2 quarters · filed 2025-10-08 | 20.00M shares derived: average of 3 quarters · filed 2025-10-08 | 20.00M shares 10-K · filed 2025-10-08 | ||
| 2024-03-31 | 20.00M shares 10-Q · filed 2025-05-15 | 20.00M shares derived: average of 2 quarters · filed 2025-05-15 | 20.00M shares 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | 20.00M shares 10-Q · filed 2025-04-15 | 20.00M shares 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |